Exelixis Clinical Site #4

St Louis, Missouri 63110

0 studies enrolling now · 2 studies all time

What they study most

Head and Neck Squamous Cell Carcinoma, Renal Cell Carcinoma

Studies at this site

• Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma — Running, not enrolling
• Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Running, not enrolling